Search Results 3481-3490 of 34733 for oral

1. Study Using Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms - Mayo Clinic

   We propose a phase I trial with oral curcumin + piperine in older cancer to derive a safe, optimal biological dose to be tested for stent symptoms in a future ...

2. Small bowel cancer - Doctors and departments - Mayo Clinic

   ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

3. Viagra for women: Does it exist? - Mayo Clinic

   For years there were no FDA-approved medicines for treating problems with sexual arousal or sexual desire in women. Yet 4 in 10 women report having sexual ...

4. A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer - Mayo Clinic

   ... oral contraceptives. An abnormal CA-125 is defined as a level > 40 U/ml for premenopausal women who are current users of oral contraceptives. Women who ...

5. A Registry for Participants with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection - Mayo Clinic

   ... oral SOF-based regimen outside a clinical study. These individuals must have documentation of the regimen, start and end of treatment dates (month and year) ...

6. A Study to Evaluate Lamprene (Clofazimine) to Treat Non-Tuberculous Mycobacterial (NTM) Infections - Mayo Clinic

   ... oral or injected or implanted hormonal contraception or intra-uterine device or with spermicidal foam/gel/film/ cream/vaginal suppository;; Use of oral ...

7. A Study to Evaluate Clazakizumab in Patients with Life-threatening COVID-19 Infection (Enrolling by Invitation Only) - Mayo Clinic

   ... (oral, intravaginal, or transdermal);; Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, implantable); ...

8. Dr. Adrian Vella Archives - Mayo Clinic News Network

   acarbose). Furthermore, by confining the recommendations to oral medications, another class of injectable medication – glucagon-like peptide-1 receptor agonists ...

9. Alex G. Boutselis, M.D. - Doctors and Medical Staff - Mayo Clinic

   Awards and honors. 2024. ASER Magna Cum Laude Oral PresentationAmerican Society of Emergency Radiology Annual Meeting. 2024. 2nd Place Oral PresentationIU ...

10. Jennifer L. Leiting, M.D. - Doctors and Medical Staff - Mayo Clinic

    Commission on Cancer Oral Presentation WinderMinnesota Surgical Society. 2018. Balfour Research Symposium Oral Presentation WinnerMayo Clinic. 2014. Alpha Omega ...